API Cost Inflation and Tariffs – What Pharma Buyers Must Know in 2025
From surging raw material prices to looming tariffs on imported APIs, pharmaceutical buyers in 2025 are undergoing inflationary pressure from every corner.
July 25, 2025
by Saher Haider
Niche API Opportunities: Chloramphenicol and Immune Regulators
The global active pharmaceutical ingredients (API) market is consistently growing, in line with the increases in size of the pharmaceutical industry.
July 18, 2025
by Suzanne Elvidge
Pharma Sources Insight July 2025: GLOBAL API SOURCING TRENDS
Pharma Sources Insight July 2025 focuses on global API sourcing trends and more.
July 11, 2025
by Pharma Sources Insight
Who Will Hold the Reins? An Analysis of Drug-Originating Countries for the US Market
This analysis reveals a paradox: 85% of APIs for U.S. branded drugs are imported (43% from Europe). Proposed tariffs threaten global supply chains, forcing pharmaceutical companies to restructure sourcing strategies.
June 19, 2025
by N55.6761
Beyond Antibiotics: The Expanding Role of Anti-Infective APIs in Bacterial Infection
Beyond antibiotics, novel anti-infective approaches include AMPs targeting biofilms, FMT capsules ,nanoparticle delivery systems, and synbiotics to combat the global AMR crisis.
June 13, 2025
by Suzanne Elvidge
Apeloa Pharmaceutical releases first ESG
Apeloa Pharmaceutical has released its first sustainability report. Apeloa’s 2024 Environmental, Social and Governance (ESG) report marks the start of continuous and responsible disclosure into the future.
May 12, 2025
by PharmaSources
API Registration Process in Pakistan
APIs are the biologically active components in pharmaceutical drugs responsible for producing the intended therapeutic effects.
April 7, 2025
by Saher Haider
Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives
Artemisinin is a sesquiterpene lactone compound with a peroxide group structure extracted from the leaves of Artemisia annua, a plant belonging to the Asteraceae family.
July 19, 2024
by Xiaomichong
Research Progress on the Protective Mechanism of Ligustrazine Against Vascular Endothelial Injury
Tetramethylpyrazine (TMP), also known as Ligustrazine, is one of the main active ingredients of Chuanxiong, an active alkaloid extracted from its rhizomes. TMP has been widely used in China to treat cardiovascular diseases such as hypertension.
July 4, 2024
by Xiaomichong
What are the types of Active Pharmaceutical Ingredient equipments?
The equipment used in the manufacturing and processing of APIs can be categorized into various types based on their specific functions and applications. Here are some common types of API equipment.
November 8, 2023
by ChatGPT/PharmaSources
FAQs About Pharmaceutical Intermediates: Definition, Types and Applications
Pharmaceutical intermediates are foundational elements in the development of active pharmaceutical ingredients (APIs).
September 11, 2023
by PharmaSources
The National Healthcare Security Administration announced a price reduction for hydrocortisone acetate tablets
The price is back to the level of about two years ago, and the result is not to stop taking the drug.
June 8, 2023
by PharmaSources/Laoxue